Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyzed Allylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel iridium-catalyzed synthesis offers high enantioselectivity for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN117209399A reveals iridium-catalyzed synthesis avoiding toxic cyanide. Delivers high purity chiral allene nitriles with significant supply chain and cost advantages.